Czech health reforms include drug tax hike

2 September 2007

The Czech Republic's Chamber of Deputies has narrowly approved the government's public sector reform package. which includes health care charges. The vote was carried by 101 votes to 99 with the help of two opposition members.

The reforms are designed to reduce the national budget deficit, which is considered crucial for the country's prospects of adopting the euro as its currency. On the fiscal side, a flat tax equivalent to 23.1% of income will replace the existing four-level system and incorporate social security payments. Value-added tax for certain goods, including drugs, will be raised from 5% to 9% in 2008 and patient charges levied of 30 koruna ($1.47) per physician visit.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight